BIA
SUPN icon

Bell Investment Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bell Investment Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49K Hold
75
– – ﹤0.01% 1123
2026
Q1 		$3.88K Hold
75
– – ﹤0.01% 1081
2025
Q4 		$3.73K Hold
75
– – ﹤0.01% 1096
2025
Q3 		$3.58K Hold
75
– – ﹤0.01% 1080
2025
Q2 		$2.36K Hold
75
– – ﹤0.01% 1307
2025
Q1 		$2.46K Hold
75
– – ﹤0.01% 1232
2024
Q4 		$2.71K Hold
75
– – ﹤0.01% 1212
2024
Q3 		$2.34K Hold
75
– – ﹤0.01% 1286
2024
Q2 		$2.01K Hold
75
– – ﹤0.01% 1351
2024
Q1 		$2.56K Hold
75
– – ﹤0.01% 1239
2023
Q4 		$2.17K Buy
75
+56
+295% +$1.49K ﹤0.01% 1296
2023
Q3 		$524 Hold
19
– – ﹤0.01% 1772
2023
Q2 		$572 Hold
19
– – ﹤0.01% 1775
2023
Q1 		$689 Sell
19
-14
-42% -$538 ﹤0.01% 1676
2022
Q4 		$1.18K Buy
33
+14
+74% +$487 ﹤0.01% 1508
2022
Q3 		$1K Hold
19
– – ﹤0.01% 1583
2022
Q2 		$1K Buy
+19
New +$544 ﹤0.01% 1612
2021
Q4 		$1K Hold
19
– – ﹤0.01% 1611
2021
Q3 		$1K Buy
+19
New +$510 ﹤0.01% 1569

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Bell Investment Advisors's SUPN Position: Q2 2026 in Review

Bell Investment Advisors held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 75 shares worth $3.49K. The position accounts for ﹤0.01% of the portfolio, ranked #1123.

Bell Investment Advisors first reported a position in SUPN in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.88K in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Bell Investment Advisors held 75 shares of Supernus Pharmaceuticals worth $3.49K as of Q2 2026.
  • Bell Investment Advisors left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #1123 holding.
  • Bell Investment Advisors first reported a position in Supernus Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Supernus Pharmaceuticals position peaked at $3.88K in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.